Sharareh Eskandari
TitleCited byYear
Brain delivery of valproic acid via intranasal administration of nanostructured lipid carriers: in vivo pharmacodynamic studies using rat electroshock model
S Eskandari, J Varshosaz, M Minaiyan, M Tabbakhian
International journal of nanomedicine 6, 363, 2011
692011
Freeze-drying of nanostructure lipid carriers by different carbohydrate polymers used as cryoprotectants
J Varshosaz, S Eskandari, M Tabbakhian
Carbohydrate polymers 88 (4), 1157-1163, 2012
612012
Production and optimization of valproic acid nanostructured lipid carriers by the Taguchi design
J Varshosaz, S Eskandari, M Tabakhian
Pharmaceutical development and technology 15 (1), 89-96, 2010
552010
Recent advances in self-assembled peptides: Implications for targeted drug delivery and vaccine engineering
S Eskandari, T Guerin, I Toth, RJ Stephenson
Advanced drug delivery reviews 110, 169-187, 2017
522017
Structure–activity relationship of lipid core peptide-based Group A Streptococcus vaccine candidates
A Chan, WM Hussein, KA Ghaffar, N Marasini, A Mostafa, S Eskandari, ...
Bioorganic & medicinal chemistry 24 (14), 3095-3101, 2016
102016
Synthesis and Characterisation of Self‐Assembled and Self‐Adjuvanting Asymmetric Multi‐Epitope Lipopeptides of Ovalbumin
S Eskandari, RJ Stephenson, AA Fuaad, SH Apte, DL Doolan, I Toth
Chemistry–A European Journal 21 (3), 1251-1261, 2015
72015
Formulation and in-vitro characterization of extended release pellets of indomethacin using powder-layering technique
S Eskandari, J Varshosaz, G Akhavanfarid, G Hafizi
Research in Pharmaceutical Sciences 2 (2), 67-75, 2009
52009
Systematic evaluation of self-adjuvanting lipopeptide nano-vaccine platforms for the induction of potent CD8+ T-cell responses
SH Apte, RJ Stephenson, P Simerska, PL Groves, S Aljohani, S Eskandari, ...
Nanomedicine 11 (2), 137-152, 2016
42016
Formulation, characterization and permeability study of nano particles of lipo-endomorphin-1 for oral delivery
S Eskandari, P Varamini, I Toth
Journal of liposome research 23 (4), 311-317, 2013
42013
Factors affecting the production of nanostructure lipid carriers of valproic acid
J Varshosaz, S Eskandari, R Kennedy, M Tabbakhian, M Minaiyan
Journal of biomedical nanotechnology 9 (2), 202-212, 2013
42013
Synthesis of mannosylated lipopeptides with receptor targeting properties
B Sedaghat, RJ Stephenson, AK Giddam, S Eskandari, SH Apte, ...
Bioconjugate chemistry 27 (3), 533-548, 2016
32016
Current boundaries in the formulation of lipid based delivery systems
S Eskandari, R Stephenson, I Toth
Liposomal delivery systems: advances and challenges. London: Future Science Ltd, 2016
12016
Arthritis and transdermal glucosamine (RahaminŽ): A brief introduction
S Eskandari
Iranian Journal of Rheumatology 1 (1), 0-0, 2012
12012
Influence of Physicochemical Properties of Lipopeptide Adjuvants on the Immune Response: A Rationale for Engineering a Potent Vaccine
S Eskandari, DJ Pattinson, RJ Stephenson, PL Groves, SH Apte, ...
Chemistry–A European Journal, 2018
2018
Synthesis and physicochemical examination of asymmetric amphoteric macromolecules containing OVA CD4 and OVA CD8 for the development of a model vaccine
S Eskandari
2016
An online subscription or single chapter purchase is required to access the chapter you requested: Current boundaries in the formulation of lipid based delivery systems
S Eskandari, R Stephenson, I Toth
P 14. Synthesis and physicochemical examination of asymmetric lipopeptide dendrimers as model vaccine candidates
S Eskandari, R Stephenson, I Toth
School of Chemistry and Molecular Biosciences, 40, 0
The system can't perform the operation now. Try again later.
Articles 1–17